Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer

Completed

Conditions studied: Cervical Cancer, Endometrial Cancer, Radiation Toxicity, Sexuality and Reproductive Issues

In brief

RATIONALE: Understanding how well patients comply with their treatment regimen may help doctors determine best treatment and ongoing care for future patients. PURPOSE: This phase I study is looking at compliance with vaginal dilation therapy in women who have undergone radiation therapy for stage IB, stage IIA, stage IIB, stage IIIA, or stage IIIB cervical cancer or stage IA, stage IB, stage IIA, or stage IIB endometrial cancer.

Key facts

Study ID

NCT00735514

Run by

Case Comprehensive Cancer Center

People needed

83

Starts

2008-07-01

Expected to finish

2010-05-01

Last updated by the study team

2019-10-08

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Geauga Regional Hospital — Cleveland, Ohio, United States
• Lake/University Ireland Cancer Center — Cleveland, Ohio, United States
• Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
• University Suburban Health Center — Cleveland, Ohio, United States
• UHHS Chagrin Highlands Medical Center — Cleveland, Ohio, United States
• Southwest General Health Center — Cleveland, Ohio, United States
• UHHS Westlake Medical Center — Cleveland, Ohio, United States
• Mercy Cancer Center at Mercy Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.